0      0


Cellular and Gene Therapy Products: A CMC Regulatory Perspective


Sep 22, 2021 3:45pm ‐ Sep 22, 2021 4:15pm


Credits: None available.

Description

Cellular and Gene Therapy Products: A CMC Regulatory Perspective |

Speaker(s):

  • Carolyn Laurencot, Associate Director for Regulatory Science and Review, Division of Cellular & G, FDA (US Food and Drug Administration)

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.